ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Baron & Budd Announces Spring 2024 Mesothelioma Cancer Victims Memorial Scholarship Winner

Scholarship winner Avery Gray shared her personal experience dealing with pediatric cancer and how it has influenced her outlook on life

Today, the national law firm Baron & Budd announced that it has selected Avery Gray as the winner of the Mesothelioma Cancer Victims Memorial Scholarship. She will receive a $2,500 scholarship paid directly to the financial aid account at her university.

Applicants were asked to submit a written or video essay about how cancer has impacted their lives. Avery Gray’s winning written essay was selected after a competitive review by the Baron & Budd Scholarship committee. Her moving essay outlined her experience of receiving a cancer diagnosis as a child, the lasting effects of the treatments, and the life lessons she learned throughout the journey.

Gray explained how the health challenges she faced influenced her career path and heightened her empathy and compassion toward others. Through her experience, she discovered a passion for medical care and plans to go to school to become a pediatrician. In her essay, Gray wrote about her interactions with healthcare workers, “The medical providers I encountered when I was ill ignited my passion for a higher medical education, and my zeal for helping those in need keeps the flame burning.” Gray is starting her first year at the University of Mary Hardin-Baylor where she will be majoring in Biochemistry.

“Avery’s enthusiasm for helping others and her personal experience with cancer will undoubtedly benefit her as she pursues a career in the medical field. We are proud to help support her education and wish her the best in all of her future endeavors,” said President and Managing Shareholder Russell Budd.

The Mesothelioma Cancer Victims Memorial Scholarship was established to honor the legacy of the thousands of Americans who are diagnosed with mesothelioma cancer every year. For more information about the Baron & Budd Mesothelioma Cancer Victims Memorial Scholarship, please visit baronandbudd.com/mesothelioma-lawyer/scholarships/.

ABOUT BARON & BUDD, P.C.

With more than 40 years of experience, Baron & Budd has the expertise and resources to handle complex litigation throughout the United States. As a law firm that takes pride in remaining at the forefront of litigation, Baron & Budd has spearheaded many significant cases for hundreds of public entities and tens of thousands of individuals. Since the firm was founded in 1977, Baron & Budd has achieved substantial national acclaim for its work on cutting-edge litigation, trying hundreds of cases to verdict and settling tens of thousands of cases in areas of litigation as diverse and significant as dangerous and highly addictive pharmaceuticals, defective medical devices, asbestos and mesothelioma, wildfires, environmental contamination, fraudulent banking practices, e-cigarettes, motor vehicles, federal whistleblower cases, and other consumer fraud issues.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.